Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLGNLGN$80.60+0.1%$85.45$26.96▼$107.24$8.70BN/A1.32 million shs3.09 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLGNLGN0.00%-5.91%-3.86%+49.40%+8,050,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLGNLGN$80.60+0.1%$85.45$26.96▼$107.24$8.70BN/A1.32 million shs3.09 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLGNLGN0.00%-5.91%-3.86%+49.40%+8,050,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLGNLGN 2.75Moderate Buy$88.409.68% UpsideCurrent Analyst Ratings BreakdownLatest LGN, GKP, and RKH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/22/2026LGNLGN BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$60.00 ➝ $80.005/19/2026LGNLGN Tigress FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$85.00 ➝ $125.005/19/2026LGNLGN BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$45.00 ➝ $60.005/15/2026LGNLGN BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$63.00 ➝ $100.005/14/2026LGNLGN BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$75.00 ➝ $120.004/29/2026LGNLGN Loop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$96.004/21/2026LGNLGN Glj ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$99.004/20/2026LGNLGN Glj ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy4/16/2026LGNLGN Tigress FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$60.00 ➝ $85.004/16/2026LGNLGN The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$63.00 ➝ $72.00(Data available from 6/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLGNLGN$2.55B3.41$0.62 per share129.61$7.49 per share10.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLGNLGN-$59.78M$0.23350.4349.15N/AN/AN/AN/AN/ALatest LGN, GKP, and RKH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026LGNLGN$0.19$0.13-$0.06$0.13N/A$1.04 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLGNLGNN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLGNLGN1.061.301.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLGNLGNN/AInsider OwnershipCompanyInsider OwnershipLGNLGN0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLGNLGN7,000108.04 million108.03 millionN/ALGN HeadlinesRecent News About These CompaniesLGN (NASDAQ:LGN) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 27 at 2:30 AM | americanbankingnews.comLigand Pharma Completes Major Convertible Notes Financing TransactionJune 25, 2026 | tipranks.comBarclays Keeps Their Hold Rating on Legence Corp. Class A (LGN)June 22, 2026 | theglobeandmail.comLigand Pharma Plans $550 Million Convertible Notes OfferingJune 22, 2026 | tipranks.comTop 3 Materials Stocks That Are Ticking Portfolio BombsJune 18, 2026 | benzinga.comLegence: Growth Has More Visibility, Still Not Enough Margin Of SafetyJune 17, 2026 | seekingalpha.comLegence Stockholders Back Directors, Pay Plan, ESPP MeasuresJune 11, 2026 | tipranks.com(LGN) Legence Corp. anticipe un chiffre d'affaires compris entre 1,05 et 1,1 milliard de dollars au T2June 10, 2026 | zonebourse.comZLigand Pharma Shareholders Back Governance and Incentive PlanJune 9, 2026 | tipranks.comA Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 MillionJune 8, 2026 | finance.yahoo.comLegence Corp. Receives Credit Rating Upgrade from S&P Global, Reducing Term Loan PricingJune 8, 2026 | quiverquant.comQLegence Announces Improved Term Loan Pricing on Credit Rating UpgradeJune 8, 2026 | globenewswire.comLegence: A Home RunJune 7, 2026 | seekingalpha.comAlign Technology Inc. (ALGN): One of the Top Stocks to Buy According to AIJune 1, 2026 | insidermonkey.comSilgan Holders Approve Amended Stock Incentive PlanMay 29, 2026 | tipranks.comHere’s What the Street is Saying About Legence Corp. (LGN)May 29, 2026 | finance.yahoo.comLegence Announces Repricing of Term LoanMay 28, 2026 | globenewswire.comAnalyst Initiates Buy on Align, Citing Growth Investments, New Initiatives, and Attractive 2026 Valuation UpsideMay 27, 2026 | tipranks.comHere’s What Lifted Legence Corp. (LGN) in Q1May 25, 2026 | insidermonkey.comHere’s What Lifted Legence Corp. (LGN) in Q1May 25, 2026 | finance.yahoo.comLegence Stock Up 185% Since IPO—Could 50% Upside Lie Ahead?...April 23, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLGN Company DescriptionsLGN NASDAQ:LGN$80.60 +0.09 (+0.11%) Closing price 04:00 PM EasternExtended Trading$80.03 -0.57 (-0.71%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Legence Corp. is a provider of engineering, consulting, installation and maintenance services for mission-critical systems in buildings. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing systems. Legence Corp. is based in SAN JOSE, Calif. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Boom Has a Second Act—And It's Playing Out in Optics Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback? 5 Tech Stocks to Buy on the July Pullback Is OpenAI’s IPO Delay a Warning for AI Investors? onsemi: What the Market Gets Wrong, You Can Get Right 5 Places Investors Can Hide If the AI Trade Keeps Cracking MarketBeat Week in Review – 06/22 - 06/26 Qualcomm’s Investor Day Just Changed the Growth Story Forever Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
